Clinigen Partners with Tepsivo For Pharmacovigilance Solutions

Clinigen, a worldwide expert in pharmaceutical services, has formed a strategic alliance with Tepsivo, a provider of digital Pharmacovigilance (PV) services. In the framework of the partnership, Clinigen has obtained a minority share in Tepsivo...

Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec

The government is expected to grant an extension until December this year for the drug manufacturers to comply with the updated Schedule M. They stated that the drug regulations will be revised to allow for an extension of time. Once the last...

US FDA Approves Eisai and Biogen's sBLA for Monthly IV Dose of Lecanemab

Eisai Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has granted approval for the Supplemental Biologics License Application (sBLA) for lecanemab-irmb, administered intravenously (IV) once every four weeks as...

How Regulations Are Shaping India's Medical Device Landscape

In a joint workshop between CDSCO and the Confederation of Indian Industry, Aseem Sahu, Deputy Drugs Controller, Medical Device Division, CDSCO, shares his view on the regulatory requirements for medical devices, components, and import...

Lupin Gains US FDA Nod to Launch Generic HIV Drug in the US Market

Pharmaceutical company Lupin announced that it has received authorization from the US health authority to commercialize generic HIV drug in the US market. The Mumbai-based drug manufacturer announced in a statement that it has obtained provisional...

Roche Secures FDA Nod and CLIA Waiver for cobas liat STI

Roche reported that the US Food and Drug Administration (FDA) has provided 510(k) clearance and a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver for its cobas liat panels for multiplex testing of sexually transmitted infections...

Poxel SA Receives CNIPA Patent for Imeglimin

Poxel SA, a biopharmaceutical firm at the clinical stage focusing on developing groundbreaking therapies for chronic serious diseases characterized by metabolic pathophysiology, such as metabolic dysfunction-associated steatohepatitis (MASH)...

US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter

Opella, the Consumer Healthcare division of Sanofi, announced that the US Food and Drug Administration (FDA) has removed a clinical hold on its proposed actual use trial (AUT) aimed at facilitating the transition of Cialis (tadalafil) from...

CCI Approves Merger of Nine Entities with Sequent Scientific

The Competition Commission approved the merger of nine entities with the pharmaceutical company Sequent Scientific Ltd (SSL). "The suggested merger entails a sequence of linked actions executed for the integration of SRL, Viyash, Symed, Appcure...

Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma

Binita Shah, Co-founder of BDR Pharmaceuticals, engaged in a conversation with India Pharma Outlook, to explain how CSR is becoming integral to HR in the Indian pharma industry, focusing on community-driven initiatives like healthcare awareness,